Global Implantable Drug-Eluting Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Implantable Drug-Eluting Devices market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Implantable Drug-Eluting Devices industry chain, the market status of Diabetes (Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices), Contraception (Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Implantable Drug-Eluting Devices.
Regionally, the report analyzes the Implantable Drug-Eluting Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Implantable Drug-Eluting Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Implantable Drug-Eluting Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Implantable Drug-Eluting Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Implantable Drug-Eluting Devices market.
Regional Analysis: The report involves examining the Implantable Drug-Eluting Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Implantable Drug-Eluting Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Implantable Drug-Eluting Devices:
Company Analysis: Report covers individual Implantable Drug-Eluting Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Implantable Drug-Eluting Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diabetes, Contraception).
Technology Analysis: Report covers specific technologies relevant to Implantable Drug-Eluting Devices. It assesses the current state, advancements, and potential future developments in Implantable Drug-Eluting Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Implantable Drug-Eluting Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Implantable Drug-Eluting Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Implantable Drug-Eluting Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Implantable Drug-Eluting Devices, with price, sales, revenue and global market share of Implantable Drug-Eluting Devices from 2019 to 2024.
Chapter 3, the Implantable Drug-Eluting Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implantable Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Implantable Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Implantable Drug-Eluting Devices.
Chapter 14 and 15, to describe Implantable Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion.
Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Implantable Drug-Eluting Devices industry chain, the market status of Diabetes (Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices), Contraception (Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Implantable Drug-Eluting Devices.
Regionally, the report analyzes the Implantable Drug-Eluting Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Implantable Drug-Eluting Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Implantable Drug-Eluting Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Implantable Drug-Eluting Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Implantable Drug-Eluting Devices market.
Regional Analysis: The report involves examining the Implantable Drug-Eluting Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Implantable Drug-Eluting Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Implantable Drug-Eluting Devices:
Company Analysis: Report covers individual Implantable Drug-Eluting Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Implantable Drug-Eluting Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diabetes, Contraception).
Technology Analysis: Report covers specific technologies relevant to Implantable Drug-Eluting Devices. It assesses the current state, advancements, and potential future developments in Implantable Drug-Eluting Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Implantable Drug-Eluting Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Implantable Drug-Eluting Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Implantable Drug Infusion Pumps
- Intraocular Drug-Eluting Devices
- Contraceptive Drug-Eluting Devices
- Drug-Eluting Stents
- Others
- Diabetes
- Contraception
- HIV/AIDS Prevention
- Chronic Pain Management
- Cardiovascular
- Ophthalmology
- Oncology
- Others
- Pfizer
- Medtronic
- Merck
- Bayer AG
- Johnson & Johnson
- Abbott
- Surmodics
- Boston Scientific Corporation
- Titan Pharmaceuticals, Inc.
- BIOTRONIK
- Allergan
- Bausch & Lomb
- REVA Medical
- MicroPort Medical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Implantable Drug-Eluting Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Implantable Drug-Eluting Devices, with price, sales, revenue and global market share of Implantable Drug-Eluting Devices from 2019 to 2024.
Chapter 3, the Implantable Drug-Eluting Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implantable Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Implantable Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Implantable Drug-Eluting Devices.
Chapter 14 and 15, to describe Implantable Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Implantable Drug-Eluting Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Implantable Drug-Eluting Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Implantable Drug Infusion Pumps
1.3.3 Intraocular Drug-Eluting Devices
1.3.4 Contraceptive Drug-Eluting Devices
1.3.5 Drug-Eluting Stents
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Implantable Drug-Eluting Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Diabetes
1.4.3 Contraception
1.4.4 HIV/AIDS Prevention
1.4.5 Chronic Pain Management
1.4.6 Cardiovascular
1.4.7 Ophthalmology
1.4.8 Oncology
1.4.9 Others
1.5 Global Implantable Drug-Eluting Devices Market Size & Forecast
1.5.1 Global Implantable Drug-Eluting Devices Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Implantable Drug-Eluting Devices Sales Quantity (2019-2030)
1.5.3 Global Implantable Drug-Eluting Devices Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Implantable Drug-Eluting Devices Product and Services
2.1.4 Pfizer Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Implantable Drug-Eluting Devices Product and Services
2.2.4 Medtronic Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medtronic Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Implantable Drug-Eluting Devices Product and Services
2.3.4 Merck Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Implantable Drug-Eluting Devices Product and Services
2.4.4 Bayer AG Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer AG Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Product and Services
2.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Implantable Drug-Eluting Devices Product and Services
2.6.4 Abbott Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Recent Developments/Updates
2.7 Surmodics
2.7.1 Surmodics Details
2.7.2 Surmodics Major Business
2.7.3 Surmodics Implantable Drug-Eluting Devices Product and Services
2.7.4 Surmodics Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Surmodics Recent Developments/Updates
2.8 Boston Scientific Corporation
2.8.1 Boston Scientific Corporation Details
2.8.2 Boston Scientific Corporation Major Business
2.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Product and Services
2.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Boston Scientific Corporation Recent Developments/Updates
2.9 Titan Pharmaceuticals, Inc.
2.9.1 Titan Pharmaceuticals, Inc. Details
2.9.2 Titan Pharmaceuticals, Inc. Major Business
2.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product and Services
2.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Titan Pharmaceuticals, Inc. Recent Developments/Updates
2.10 BIOTRONIK
2.10.1 BIOTRONIK Details
2.10.2 BIOTRONIK Major Business
2.10.3 BIOTRONIK Implantable Drug-Eluting Devices Product and Services
2.10.4 BIOTRONIK Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 BIOTRONIK Recent Developments/Updates
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business
2.11.3 Allergan Implantable Drug-Eluting Devices Product and Services
2.11.4 Allergan Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Allergan Recent Developments/Updates
2.12 Bausch & Lomb
2.12.1 Bausch & Lomb Details
2.12.2 Bausch & Lomb Major Business
2.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Product and Services
2.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bausch & Lomb Recent Developments/Updates
2.13 REVA Medical
2.13.1 REVA Medical Details
2.13.2 REVA Medical Major Business
2.13.3 REVA Medical Implantable Drug-Eluting Devices Product and Services
2.13.4 REVA Medical Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 REVA Medical Recent Developments/Updates
2.14 MicroPort Medical
2.14.1 MicroPort Medical Details
2.14.2 MicroPort Medical Major Business
2.14.3 MicroPort Medical Implantable Drug-Eluting Devices Product and Services
2.14.4 MicroPort Medical Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 MicroPort Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMPLANTABLE DRUG-ELUTING DEVICES BY MANUFACTURER
3.1 Global Implantable Drug-Eluting Devices Sales Quantity by Manufacturer (2019-2024)
3.2 Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2019-2024)
3.3 Global Implantable Drug-Eluting Devices Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Implantable Drug-Eluting Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Implantable Drug-Eluting Devices Manufacturer Market Share in 2023
3.4.2 Top 6 Implantable Drug-Eluting Devices Manufacturer Market Share in 2023
3.5 Implantable Drug-Eluting Devices Market: Overall Company Footprint Analysis
3.5.1 Implantable Drug-Eluting Devices Market: Region Footprint
3.5.2 Implantable Drug-Eluting Devices Market: Company Product Type Footprint
3.5.3 Implantable Drug-Eluting Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Implantable Drug-Eluting Devices Market Size by Region
4.1.1 Global Implantable Drug-Eluting Devices Sales Quantity by Region (2019-2030)
4.1.2 Global Implantable Drug-Eluting Devices Consumption Value by Region (2019-2030)
4.1.3 Global Implantable Drug-Eluting Devices Average Price by Region (2019-2030)
4.2 North America Implantable Drug-Eluting Devices Consumption Value (2019-2030)
4.3 Europe Implantable Drug-Eluting Devices Consumption Value (2019-2030)
4.4 Asia-Pacific Implantable Drug-Eluting Devices Consumption Value (2019-2030)
4.5 South America Implantable Drug-Eluting Devices Consumption Value (2019-2030)
4.6 Middle East and Africa Implantable Drug-Eluting Devices Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
5.2 Global Implantable Drug-Eluting Devices Consumption Value by Type (2019-2030)
5.3 Global Implantable Drug-Eluting Devices Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
6.2 Global Implantable Drug-Eluting Devices Consumption Value by Application (2019-2030)
6.3 Global Implantable Drug-Eluting Devices Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
7.2 North America Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
7.3 North America Implantable Drug-Eluting Devices Market Size by Country
7.3.1 North America Implantable Drug-Eluting Devices Sales Quantity by Country (2019-2030)
7.3.2 North America Implantable Drug-Eluting Devices Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
8.2 Europe Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
8.3 Europe Implantable Drug-Eluting Devices Market Size by Country
8.3.1 Europe Implantable Drug-Eluting Devices Sales Quantity by Country (2019-2030)
8.3.2 Europe Implantable Drug-Eluting Devices Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Implantable Drug-Eluting Devices Market Size by Region
9.3.1 Asia-Pacific Implantable Drug-Eluting Devices Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Implantable Drug-Eluting Devices Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
10.2 South America Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
10.3 South America Implantable Drug-Eluting Devices Market Size by Country
10.3.1 South America Implantable Drug-Eluting Devices Sales Quantity by Country (2019-2030)
10.3.2 South America Implantable Drug-Eluting Devices Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Implantable Drug-Eluting Devices Market Size by Country
11.3.1 Middle East & Africa Implantable Drug-Eluting Devices Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Implantable Drug-Eluting Devices Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Implantable Drug-Eluting Devices Market Drivers
12.2 Implantable Drug-Eluting Devices Market Restraints
12.3 Implantable Drug-Eluting Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Implantable Drug-Eluting Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Implantable Drug-Eluting Devices
13.3 Implantable Drug-Eluting Devices Production Process
13.4 Implantable Drug-Eluting Devices Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Implantable Drug-Eluting Devices Typical Distributors
14.3 Implantable Drug-Eluting Devices Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Implantable Drug-Eluting Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Implantable Drug-Eluting Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Implantable Drug Infusion Pumps
1.3.3 Intraocular Drug-Eluting Devices
1.3.4 Contraceptive Drug-Eluting Devices
1.3.5 Drug-Eluting Stents
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Implantable Drug-Eluting Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Diabetes
1.4.3 Contraception
1.4.4 HIV/AIDS Prevention
1.4.5 Chronic Pain Management
1.4.6 Cardiovascular
1.4.7 Ophthalmology
1.4.8 Oncology
1.4.9 Others
1.5 Global Implantable Drug-Eluting Devices Market Size & Forecast
1.5.1 Global Implantable Drug-Eluting Devices Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Implantable Drug-Eluting Devices Sales Quantity (2019-2030)
1.5.3 Global Implantable Drug-Eluting Devices Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Implantable Drug-Eluting Devices Product and Services
2.1.4 Pfizer Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Implantable Drug-Eluting Devices Product and Services
2.2.4 Medtronic Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medtronic Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Implantable Drug-Eluting Devices Product and Services
2.3.4 Merck Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Implantable Drug-Eluting Devices Product and Services
2.4.4 Bayer AG Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer AG Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Product and Services
2.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Implantable Drug-Eluting Devices Product and Services
2.6.4 Abbott Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Recent Developments/Updates
2.7 Surmodics
2.7.1 Surmodics Details
2.7.2 Surmodics Major Business
2.7.3 Surmodics Implantable Drug-Eluting Devices Product and Services
2.7.4 Surmodics Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Surmodics Recent Developments/Updates
2.8 Boston Scientific Corporation
2.8.1 Boston Scientific Corporation Details
2.8.2 Boston Scientific Corporation Major Business
2.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Product and Services
2.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Boston Scientific Corporation Recent Developments/Updates
2.9 Titan Pharmaceuticals, Inc.
2.9.1 Titan Pharmaceuticals, Inc. Details
2.9.2 Titan Pharmaceuticals, Inc. Major Business
2.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product and Services
2.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Titan Pharmaceuticals, Inc. Recent Developments/Updates
2.10 BIOTRONIK
2.10.1 BIOTRONIK Details
2.10.2 BIOTRONIK Major Business
2.10.3 BIOTRONIK Implantable Drug-Eluting Devices Product and Services
2.10.4 BIOTRONIK Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 BIOTRONIK Recent Developments/Updates
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business
2.11.3 Allergan Implantable Drug-Eluting Devices Product and Services
2.11.4 Allergan Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Allergan Recent Developments/Updates
2.12 Bausch & Lomb
2.12.1 Bausch & Lomb Details
2.12.2 Bausch & Lomb Major Business
2.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Product and Services
2.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bausch & Lomb Recent Developments/Updates
2.13 REVA Medical
2.13.1 REVA Medical Details
2.13.2 REVA Medical Major Business
2.13.3 REVA Medical Implantable Drug-Eluting Devices Product and Services
2.13.4 REVA Medical Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 REVA Medical Recent Developments/Updates
2.14 MicroPort Medical
2.14.1 MicroPort Medical Details
2.14.2 MicroPort Medical Major Business
2.14.3 MicroPort Medical Implantable Drug-Eluting Devices Product and Services
2.14.4 MicroPort Medical Implantable Drug-Eluting Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 MicroPort Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMPLANTABLE DRUG-ELUTING DEVICES BY MANUFACTURER
3.1 Global Implantable Drug-Eluting Devices Sales Quantity by Manufacturer (2019-2024)
3.2 Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2019-2024)
3.3 Global Implantable Drug-Eluting Devices Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Implantable Drug-Eluting Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Implantable Drug-Eluting Devices Manufacturer Market Share in 2023
3.4.2 Top 6 Implantable Drug-Eluting Devices Manufacturer Market Share in 2023
3.5 Implantable Drug-Eluting Devices Market: Overall Company Footprint Analysis
3.5.1 Implantable Drug-Eluting Devices Market: Region Footprint
3.5.2 Implantable Drug-Eluting Devices Market: Company Product Type Footprint
3.5.3 Implantable Drug-Eluting Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Implantable Drug-Eluting Devices Market Size by Region
4.1.1 Global Implantable Drug-Eluting Devices Sales Quantity by Region (2019-2030)
4.1.2 Global Implantable Drug-Eluting Devices Consumption Value by Region (2019-2030)
4.1.3 Global Implantable Drug-Eluting Devices Average Price by Region (2019-2030)
4.2 North America Implantable Drug-Eluting Devices Consumption Value (2019-2030)
4.3 Europe Implantable Drug-Eluting Devices Consumption Value (2019-2030)
4.4 Asia-Pacific Implantable Drug-Eluting Devices Consumption Value (2019-2030)
4.5 South America Implantable Drug-Eluting Devices Consumption Value (2019-2030)
4.6 Middle East and Africa Implantable Drug-Eluting Devices Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
5.2 Global Implantable Drug-Eluting Devices Consumption Value by Type (2019-2030)
5.3 Global Implantable Drug-Eluting Devices Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
6.2 Global Implantable Drug-Eluting Devices Consumption Value by Application (2019-2030)
6.3 Global Implantable Drug-Eluting Devices Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
7.2 North America Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
7.3 North America Implantable Drug-Eluting Devices Market Size by Country
7.3.1 North America Implantable Drug-Eluting Devices Sales Quantity by Country (2019-2030)
7.3.2 North America Implantable Drug-Eluting Devices Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
8.2 Europe Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
8.3 Europe Implantable Drug-Eluting Devices Market Size by Country
8.3.1 Europe Implantable Drug-Eluting Devices Sales Quantity by Country (2019-2030)
8.3.2 Europe Implantable Drug-Eluting Devices Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Implantable Drug-Eluting Devices Market Size by Region
9.3.1 Asia-Pacific Implantable Drug-Eluting Devices Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Implantable Drug-Eluting Devices Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
10.2 South America Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
10.3 South America Implantable Drug-Eluting Devices Market Size by Country
10.3.1 South America Implantable Drug-Eluting Devices Sales Quantity by Country (2019-2030)
10.3.2 South America Implantable Drug-Eluting Devices Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Implantable Drug-Eluting Devices Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Implantable Drug-Eluting Devices Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Implantable Drug-Eluting Devices Market Size by Country
11.3.1 Middle East & Africa Implantable Drug-Eluting Devices Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Implantable Drug-Eluting Devices Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Implantable Drug-Eluting Devices Market Drivers
12.2 Implantable Drug-Eluting Devices Market Restraints
12.3 Implantable Drug-Eluting Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Implantable Drug-Eluting Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Implantable Drug-Eluting Devices
13.3 Implantable Drug-Eluting Devices Production Process
13.4 Implantable Drug-Eluting Devices Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Implantable Drug-Eluting Devices Typical Distributors
14.3 Implantable Drug-Eluting Devices Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
